2023

Welsh, S. A., Hussey, K., Brittenden, J. , Orr, D. J. and Quinn, T. (2023) Frailty Assessment in Vascular OUtpatients Review (FAVOUR) PROTOCOL – single-centre prospective cohort study comparing feasibility and prognostic value of commonly used frailty assessment tools. BMJ Open, 13, e079387. (doi: 10.1136/bmjopen-2023-079387)

2022

Kingsmore, D. and Brittenden, J. (2022) Sex equality or sex equity: what are we looking for in treating limb-threatening ischaemia? European Heart Journal, 43(18), pp. 1771-1773. (doi: 10.1093/eurheartj/ehac047) (PMID:35137028)

2020

Crawford, F. et al. (2020) Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model. Health Technology Assessment, 24(62), (doi: 10.3310/hta24620)

2019

Brittenden, J. et al. (2019) Five-Year outcomes of a randomized trial of treatments for varicose veins. New England Journal of Medicine, 381(10), pp. 912-922. (doi: 10.1056/nejmoa1805186) (PMID:31483962)

2018

Abaraogu, U., Ezenwankwo, E., Dall, P., Tew, G., Stuart, W., Brittenden, J. and Seenan, C. (2018) Barriers and enablers to walking in individuals with intermittent claudication: a systematic review to conceptualize a relevant and patient-centered program. PLoS ONE, 13(7), e0201095. (doi: 10.1371/journal.pone.0201095) (PMID:30048501) (PMCID:PMC6062088)

2016

Cotton, S.C., MacLennan, G., Brittenden, J. , Prior, M. and Francis, J. (2016) Behavioural recovery after treatment for varicose veins. British Journal of Surgery, 103(4), pp. 374-381. (doi: 10.1002/bjs.10081) (PMID:26805720) (PMCID:PMC4819709)

2015

Staniszewska, A., Rajagopalan, S., Al-Shaheen, A., Thies, F. and Brittenden, J. (2015) Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease. Journal of Vascular Surgery, 61(5), pp. 1292-1298. (doi: 10.1016/j.jvs.2015.01.002) (PMID:25776186)

Brittenden, J. et al. (2015) Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment, 19(27), pp. 1-342. (doi: 10.3310/hta19270) (PMID:25858333)

2014

Tassie, E., Scotland, G., Brittenden, J. , Cotton, S.C., Elders, A., Campbell, M.K., Campbell, B., Gough, M., Burr, J.M. and Ramsay, C.R. (2014) Cost-effectiveness of ultrasound-guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery, 101(12), pp. 1532-1540. (doi: 10.1002/bjs.9595) (PMID:25274220)

Brittenden, J. et al. (2014) A randomized trial comparing treatments for varicose veins. New England Journal of Medicine, 371(13), pp. 1218-1227. (doi: 10.1056/NEJMoa1400781) (PMID:25251616)

Shaikh, S., Welch, A., Ramalingam, S.L., Murray, A., Wilson, H.M., McKiddie, F. and Brittenden, J. (2014) Comparison of fluorodeoxyglucose uptake in symptomatic carotid artery and stable femoral artery plaques. British Journal of Surgery, 101(4), pp. 363-370. (doi: 10.1002/bjs.9403) (PMID:24536009)

Brittenden, J. (2014) Ramipril improves walking times and quality of life in patients with stable intermittent claudication. Evidence Based Medicine, 19(1), p. 16. (doi: 10.1136/eb-2013-101301) (PMID:23842688)

Ford, I., Scott, N. W., Herd, V., Mitchell, L. R., Williams, D. J.P. and Brittenden, J. (2014) A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease. Journal of the American College of Cardiology, 63(3), pp. 233-239. (doi: 10.1016/j.jacc.2013.10.018) (PMID:24211510)

2011

Cuthbertson, B. H. et al. (2011) A pragmatic multi-centre randomised controlled trial of fluid loading in high-risk surgical patients undergoing major elective surgery - the FOCCUS study. Critical Care, 15, R296. (doi: 10.1186/cc10592) (PMID:22177541) (PMCID:PMC3388651)

Articles

Welsh, S. A., Hussey, K., Brittenden, J. , Orr, D. J. and Quinn, T. (2023) Frailty Assessment in Vascular OUtpatients Review (FAVOUR) PROTOCOL – single-centre prospective cohort study comparing feasibility and prognostic value of commonly used frailty assessment tools. BMJ Open, 13, e079387. (doi: 10.1136/bmjopen-2023-079387)

Kingsmore, D. and Brittenden, J. (2022) Sex equality or sex equity: what are we looking for in treating limb-threatening ischaemia? European Heart Journal, 43(18), pp. 1771-1773. (doi: 10.1093/eurheartj/ehac047) (PMID:35137028)

Crawford, F. et al. (2020) Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model. Health Technology Assessment, 24(62), (doi: 10.3310/hta24620)

Brittenden, J. et al. (2019) Five-Year outcomes of a randomized trial of treatments for varicose veins. New England Journal of Medicine, 381(10), pp. 912-922. (doi: 10.1056/nejmoa1805186) (PMID:31483962)

Abaraogu, U., Ezenwankwo, E., Dall, P., Tew, G., Stuart, W., Brittenden, J. and Seenan, C. (2018) Barriers and enablers to walking in individuals with intermittent claudication: a systematic review to conceptualize a relevant and patient-centered program. PLoS ONE, 13(7), e0201095. (doi: 10.1371/journal.pone.0201095) (PMID:30048501) (PMCID:PMC6062088)

Cotton, S.C., MacLennan, G., Brittenden, J. , Prior, M. and Francis, J. (2016) Behavioural recovery after treatment for varicose veins. British Journal of Surgery, 103(4), pp. 374-381. (doi: 10.1002/bjs.10081) (PMID:26805720) (PMCID:PMC4819709)

Staniszewska, A., Rajagopalan, S., Al-Shaheen, A., Thies, F. and Brittenden, J. (2015) Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease. Journal of Vascular Surgery, 61(5), pp. 1292-1298. (doi: 10.1016/j.jvs.2015.01.002) (PMID:25776186)

Brittenden, J. et al. (2015) Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technology Assessment, 19(27), pp. 1-342. (doi: 10.3310/hta19270) (PMID:25858333)

Tassie, E., Scotland, G., Brittenden, J. , Cotton, S.C., Elders, A., Campbell, M.K., Campbell, B., Gough, M., Burr, J.M. and Ramsay, C.R. (2014) Cost-effectiveness of ultrasound-guided foam sclerotherapy, endovenous laser ablation or surgery as treatment for primary varicose veins from the randomized CLASS trial. British Journal of Surgery, 101(12), pp. 1532-1540. (doi: 10.1002/bjs.9595) (PMID:25274220)

Brittenden, J. et al. (2014) A randomized trial comparing treatments for varicose veins. New England Journal of Medicine, 371(13), pp. 1218-1227. (doi: 10.1056/NEJMoa1400781) (PMID:25251616)

Shaikh, S., Welch, A., Ramalingam, S.L., Murray, A., Wilson, H.M., McKiddie, F. and Brittenden, J. (2014) Comparison of fluorodeoxyglucose uptake in symptomatic carotid artery and stable femoral artery plaques. British Journal of Surgery, 101(4), pp. 363-370. (doi: 10.1002/bjs.9403) (PMID:24536009)

Brittenden, J. (2014) Ramipril improves walking times and quality of life in patients with stable intermittent claudication. Evidence Based Medicine, 19(1), p. 16. (doi: 10.1136/eb-2013-101301) (PMID:23842688)

Ford, I., Scott, N. W., Herd, V., Mitchell, L. R., Williams, D. J.P. and Brittenden, J. (2014) A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease. Journal of the American College of Cardiology, 63(3), pp. 233-239. (doi: 10.1016/j.jacc.2013.10.018) (PMID:24211510)

Cuthbertson, B. H. et al. (2011) A pragmatic multi-centre randomised controlled trial of fluid loading in high-risk surgical patients undergoing major elective surgery - the FOCCUS study. Critical Care, 15, R296. (doi: 10.1186/cc10592) (PMID:22177541) (PMCID:PMC3388651)